Accordingly, elevated blood concentrations of total extracellular vesicles and CD133+ (transmembrane protein expressed in stem cells) EVs before treatment are correlated with shorter overall survival of patients with metastatic colorectal cancer. The gene discussed is PROM1; the disease is metastatic colorectal cancer.